ArticleInternational journal of medical sciences2016

EphB4/ephrinB2 Contributes to Imatinib Resistance in Chronic Myeloid Leukemia Involved in Cytoskeletal Proteins.

Lin Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.